Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Baptiste Le Calvez, Benoit Tessoullin, Loïc Renaud, Carmen Botella-Garcia, Micha Srour, Steven Le Gouill, Gaelle Guillerm, Rémy Gressin, Stéphanie Nguyen Quoc, Sabine Furst, Adrien Chauchet, David Sibon, Philippe Lewalle, Xavier Poiré, Natacha Maillard, Alban Villate, Michael Loschi, Jérôme Paillassa, Yves Beguin, Rémy Dulery, Jean-Jacques Tudesq, Amandine Fayard, Marie C. Béné, Vincent Camus, Patrice Chevallier & Amandine Le Bourgeois. (2022) Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study. Acta Oncologica 61:11, pages 1332-1338.
Read now
Read now
Jitender Takyar, Monika Raut, Rebekah Borse, Arun Balakumaran & Manu Sehgal. (2020) Relapsed/refractory primary mediastinal large B-cell lymphoma: a structured review of epidemiology, treatment guidelines and real-world treatment practices. Expert Review of Hematology 13:3, pages 275-287.
Read now
Read now
Marcus Messmer, Hua-Ling Tsai, Ravi Varadhan, Lode J. Swinnen, Richard J. Jones, Richard F. Ambinder, Satish P. Shanbhag, Michael J. Borowitz & Nina Wagner-Johnston. (2019) R-CHOP without radiation in frontline management of primary mediastinal B-cell lymphoma. Leukemia & Lymphoma 60:5, pages 1261-1265.
Read now
Read now
Xiaojian Liu, Ting Deng, Xianzhi Guo, Ye Guo, Leiping Wang, Jian Zhang, Zuguang Xia, Quanling Zhang, Kai Xue, Junning Cao, Jumei Shi & Xiaonan Hong. (2017) A retrospective analysis of outcomes for primary mediastinal large B-cell lymphoma treated with RCHOP followed by radiotherapy or front-line autologous stem cell transplantation. Hematology 22:5, pages 258-264.
Read now
Read now
Michael S. Binkley, Susan M. Hiniker, Sharon Wu, Yasodha Natkunam, Erik S. Mittra, Ranjana H. Advani & Richard T. Hoppe. (2016) A single-institution retrospective analysis of outcomes for stage I–II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy. Leukemia & Lymphoma 57:3, pages 604-608.
Read now
Read now
Maurizio Martelli, Alice Di Rocco, Eleonora Russo, Salvatore Perrone & Robin Foà. (2015) Primary mediastinal lymphoma: diagnosis and treatment options. Expert Review of Hematology 8:2, pages 173-186.
Read now
Read now
Chan Y. Cheah, Michael S. Hofman, John F. Seymour, David S. Ritchie, Michael Dickinson, Andrew Wirth, H. Miles Prince, Max Wolf, Elchanan H. Januszcewicz, Dennis A. Carney, Kirsten E. Herbert, Simon J. Harrison, Kate L. Burbury & Constantine S. Tam. (2015) The utility and limitations of 18F-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review. Leukemia & Lymphoma 56:1, pages 49-56.
Read now
Read now
Articles from other publishers (59)
Charbel Soueidy & Hampig Raphael Kourie. (2023) Updates in the Management of Primary Mediastinal B Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 23:12, pages 866-873.
Crossref
Crossref
Courtney Kolberg, Elizabeth Doman, Salvatore Mignano, Dolores Mullikin, Lauren Vasta, William Wadzinski & Brian Foster. (2023) Recognizing a Mediastinal Mass: A Case of Primary Mediastinal Large B-Cell Lymphoma With Pruritus in a 23-Year-Old Adult Male Sailor. Military Medicine 188:11-12, pages 3687-3691.
Crossref
Crossref
Theodoros P. Vassilakopoulos, Fotios Panitsas, Zois Mellios, John Apostolidis, Michalis Michael, Ronit Gurion, Burhan Ferhanoglu, Eleftheria Hatzimichael, Stamatios Karakatsanis, Maria Dimou, Christina Kalpadakis, Eirini Katodritou, Theoni Leonidopoulou, Ioannis Kotsianidis, Hara Giatra, Nick Kanellias, Ayman Sayyed, Tamar Tadmor, Olga Meltem Akay, Maria K. Angelopoulou, Netanel Horowitz, Maria Bakiri, Gerassimos A. Pangalis, Panayiotis Panayiotidis & Sotirios G. Papageorgiou. (2022) Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era. Hematological Oncology 41:1, pages 97-107.
Crossref
Crossref
N. G. Gabeeva, D. A. Koroleva, S. A. Tatarnikova, A. K. Smolianinova, D. S. Badmazhapova, S. Yu. Smirnova, E. E. Nikulina, A. V. Belyaeva, E. G. Gemdzhian, V. A. Lapin, E. R. Moskalets, I. E. Kostina, Y. K. Mangasarova, S. A. Shutov, B. V. Biderman, A. B. Sudarikov, T. N. Obukhova, A. M. Kovrigina, G. M. Galstyan & E. E. Zvonkov. (2022) Interim results of the PML-16, PML-19 protocols for primary mediastinal large B-cell lymphoma therapy. Russian journal of hematology and transfusiology 67:3, pages 328-350.
Crossref
Crossref
Kerry J. Savage. (2022) Primary mediastinal large B-cell lymphoma. Blood 140:9, pages 955-970.
Crossref
Crossref
Joanna Romejko-Jarosinska, Beata Ostrowska, Anna Dabrowska-Iwanicka, Katarzyna Domanska-Czyz, Grzegorz Rymkiewicz, Ewa Paszkiewicz-Kozik, Robert Konecki, Anna Borawska, Agnieszka Druzd-Sitek, Elzbieta Lampka, Wlodzimierz Osiadacz, Michal Osowiecki, Lidia Popławska, Monika Swierkowska, Lukasz Targonski, Joanna Tajer, Grazyna Lapinska, Malwina Smorczewska & Jan Walewski. (2022) High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up. Scientific Reports 12:1.
Crossref
Crossref
Rodrigo Dolphini Velasques, Wellington F da Silva, Marcelo Bellesso, Vanderson Rocha & Juliana Pereira. (2022) Less Intensive Regimens May Still Be Suitable for the Initial Treatment of Primary Mediastinal B-Cell Lymphoma in Resource-Limited Settings. Journal of Oncology 2022, pages 1-9.
Crossref
Crossref
Ana Carolina Freitas, Inês Patrocínio Carvalho, Susana Esteves, Lucília Salgado & Maria Gomes da Silva. (2021) End of treatment FDG‐PET in primary mediastinal B‐cell lymphoma treated with R‐chemotherapy: Prognostic indicator and implications for consolidation radiotherapy. European Journal of Haematology 108:2, pages 118-124.
Crossref
Crossref
Yael Morgenstern, Shlomzion Aumann, Neta Goldschmidt, Moshe E. Gatt, Boaz Nachmias & Netanel A. Horowitz. (2021) Dose‐adjusted EPOCH‐R is not superior to sequential R‐CHOP/R‐ICE as a frontline treatment for newly diagnosed primary mediastinal B‐cell lymphoma: Results of a bi‐center retrospective study. Cancer Medicine 10:24, pages 8866-8875.
Crossref
Crossref
Yating Yu, Xifeng Dong, Meifeng Tu & Huaquan Wang. (2021)
Primary mediastinal large
B
cell lymphoma
. Thoracic Cancer 12:21, pages 2831-2837.
Crossref
Crossref
Theodoros P. Vassilakopoulos, Sotirios G. Papageorgiou, Maria K. Angelopoulou, Sophia Chatziioannou, Vassilios Prassopoulos, Stamatios Karakatsanis, Maria Arapaki, Zois Mellios, Sotirios Sachanas, Christina Kalpadakis, Eirini Katodritou, Theoni Leonidopoulou, Ioannis Kotsianidis, Eleftheria Hatzimichael, Maria Kotsopoulou, Maria Dimou, Eleni Variamis, Dimitrios Boutsis, Evangelos Terpos, Evridiki Michali, George Karianakis, Pantelis Tsirkinidis, Chryssa Vadikolia, Christos Poziopoulos, Anna Pigaditou, Effimia Vrakidou, Marina P. Siakantaris, Marie-Christine Kyrtsonis, Argyris Symeonidis, Konstantinos Anargyrou, Maria Papaioannou, Evdoxia Chatziharissi, Elissavet Vervessou, Maria Tsirogianni, Maria Palassopoulou, Gabriella Gainaru, Catherine Mainta, Panagiotis Tsirigotis, Theodora Assimakopoulou, Pavlina Konstantinidou, Helen Papadaki, Meletios-Athanassios Dimopoulos, Vassiliki Pappa, Themis Karmiris, Paraskevi Roussou, Ioannis Datseris, Panayiotis Panayiotidis, Kostas Konstantopoulos, Gerassimos A. Pangalis & Phivi Rondogianni. (2021) Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies. Annals of Hematology 100:9, pages 2279-2292.
Crossref
Crossref
Stamatis Karakatsanis, Sotirios G. Papageorgiou, Michail Michail, Maria K. Angelopoulou, Christina Kalpadakis, Theoni Leonidopoulou, Eirini Katodritou, Maria Kotsopoulou, Ioannis Kotsianidis, Eleftheria Hatzimichael, Eleftheria Lakiotaki, Dimitrios Boutsis, George Karianakis, Argiris Symeonidis, Maria Gavriatopoulou, Panayiotis Panayiotidis, Kostas Konstantopoulos, Themis Karmiris, Gerassimos A. Pangalis & Theodoros P. Vassilakopoulos. (2021) Subdiaphragmatic extranodal localizations at diagnosis of primary mediastinal large B-cell lymphoma: an impressive, rare presentation with no independent effect on prognosis. Leukemia Research 107, pages 106595.
Crossref
Crossref
Theodoros P. Vassilakopoulos, Michail Michail, Sotirios Papageorgiou, Georgia Kourti, Maria K. Angelopoulou, Fotios Panitsas, Sotirios Sachanas, Christina Kalpadakis, Eirini Katodritou, Theoni Leonidopoulou, Ioannis Kotsianidis, Eleftheria Hatzimichael, Maria Kotsopoulou, Maria Dimou, Eleni Variamis, Dimitrios Boutsis, Evangelos Terpos, Maria N. Dimopoulou, Stamatios Karakatsanis, Eurydiki Michalis, George Karianakis, Pantelis Tsirkinidis, Chryssa Vadikolia, Christos Poziopoulos, Anna Pigaditou, Effimia Vrakidou, Theophanis Economopoulos, Lydia Kyriazopoulou, Marina P. Siakantaris, Marie-Christine Kyrtsonis, Argyris Symeonidis, Konstantinos Anargyrou, Maria Papaioannou, Evdoxia Hatjiharissi, Elissavet Vervessou, Maria Tsirogianni, Maria Palassopoulou, Gabriella Gainaru, Ekaterini Stefanoudaki, Panayiotis Zikos, Panayiotis Tsirigotis, Gerasimos Tsourouflis, Theodora Assimakopoulou, Pavlina Konstantinidou, Helen A. Papadaki, Katerina Megalakaki, Meletios-Athanasios Dimopoulos, Vassiliki Pappa, Themis Karmiris, Paraskevi Roussou, Panayiotis Panayiotidis, Kostas Konstantopoulos & Gerassimos A. Pangalis. (2021) Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP. The Oncologist 26:7, pages 597-609.
Crossref
Crossref
Huan Chen, Tao Pan, Yizi He, Ruolan Zeng, Yajun Li, Liming Yi, Hui Zang, Siwei Chen, Qintong Duan, Ling Xiao & Hui Zhou. (2021) Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions. Frontiers in Oncology 11.
Crossref
Crossref
Gabriela Llaurador & Lisa Giulino-Roth. (2021) AYA Considerations for Aggressive Lymphomas. Current Hematologic Malignancy Reports 16:1, pages 61-71.
Crossref
Crossref
Bita Fakhri & Weiyun Ai. (2021) Current and emerging treatment options in primary mediastinal B-cell lymphoma. Therapeutic Advances in Hematology 12, pages 204062072110489.
Crossref
Crossref
Jakub Svoboda, Steven M. Bair, Daniel J. Landsburg, Sunita Dwivedy Nasta, Sarah J. Nagle, Stefan K. Barta, Nadia Khan, Joanne Filicko-O'Hara, Sameh Gaballa, Lauren Strelec, Elise Chong, Sheryl Mitnick, Terease S. Waite, Cara King, Hatcher Ballard, Matthew Youngman, James Gerson, John P. Plastaras, Amit Maity, Agata M. Bogusz, Stacy S. Hung, Hisae Nakamura, Reza Nejati, Christian Steidl, Megan Lim, Marco Ruella & Stephen J. Schuster. (2020) Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas. Haematologica 106:6, pages 1705-1713.
Crossref
Crossref
Hui Zhou, Zijun Y. Xu-Monette, Ling Xiao, Paolo Strati, Fredrick B. Hagemeister, Yizi He, Huan Chen, Yajun Li, Ganiraju C. Manyam, Yong Li, Santiago Montes-Moreno, Miguel A. Piris & Ken H. Young. (2020) Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up. Blood Cancer Journal 10:5.
Crossref
Crossref
Veronika Bachanova, Miguel-Angel Perales & Jeremy S. Abramson. (2020) Modern management of relapsed and refractory aggressive B-cell lymphoma: A perspective on the current treatment landscape and patient selection for CAR T-cell therapy. Blood Reviews 40, pages 100640.
Crossref
Crossref
Agata Malenda, Agnieszka Kołkowska‐Leśniak, Bartosz Puła, Monika Długosz‐Danecka, Monika Chełstowska, Agnieszka Końska, Agnieszka Giza, Ewa Lech‐Marańda, Wojciech Jurczak & Krzysztof Warzocha. (2019) Outcomes of treatment with dose‐adjusted EPOCH‐R or R‐CHOP in primary mediastinal large B‐cell lymphoma. European Journal of Haematology 104:1, pages 59-66.
Crossref
Crossref
Jeremy S. Abramson. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
1926
1947.e5
.
Christin B. DeStefano, Kieron Dunleavy & Catherine Lai. 2020. Novel Therapeutics for Rare Lymphomas. Novel Therapeutics for Rare Lymphomas
83
100
.
Alex F. Herrera, Lu Chen, Sirin Khajavian, Matthew Chase, Justin Darrah, David Maloney, Vincent T. Ho, Robert J. Soiffer, Joseph H. Antin, Stephen J. Forman, Auayporn P. Nademanee, Yi-Bin Chen, Philippe Armand & Mazyar Shadman. (2019) Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell Lymphoma. Biology of Blood and Marrow Transplantation 25:12, pages 2383-2387.
Crossref
Crossref
Jeremy S. Abramson. (2019) Hitting back at lymphoma: How do modern diagnostics identify high‐risk diffuse large B‐cell lymphoma subsets and alter treatment?. Cancer 125:18, pages 3111-3120.
Crossref
Crossref
Esther Hian Li Chan, Liang Piu Koh, Joanne Lee, Sanjay De Mel, Anand Jeyasekharan, Xin Liu, Tiffany Tang, Soon Thye Lim, Miriam Tao, Richard Quek, Mohamad Farid Bin Harunal Ras, Yuh Shan Lee, Colin Diong, Daryl Tan, Seok Jin Kim, Yen Lin Chee & Li Mei Michelle Poon. (2019) Real world experience of R‐CHOP with or without consolidative radiotherapy vs DA‐EPOCH‐R in the first‐line treatment of primary mediastinal B‐cell lymphoma. Cancer Medicine 8:10, pages 4626-4632.
Crossref
Crossref
Charlotte Lees, Colm Keane, Maher K. Gandhi & Jay Gunawardana. (2019) Biology and therapy of primary mediastinal B‐cell lymphoma: current status and future directions. British Journal of Haematology 185:1, pages 25-41.
Crossref
Crossref
Christopher Melani, Wyndham H. Wilson & Mark Roschewski. (2018)
What is the standard of care for primary mediastinal b‐cell lymphoma; R‐
CHOP
or
DA
‐
EPOCH
‐R?
. British Journal of Haematology 184:5, pages 836-838.
Crossref
Crossref
Nirav N. Shah, Timothy S. Fenske, Mehdi Hamadani & Jakub Svoboda. (2018)
What is the standard of care for primary mediastinal B cell lymphoma; R‐
CHOP
or
DA
‐
EPOCH
‐R? – Response to Melani
et al
. British Journal of Haematology 184:5, pages 838-840.
Crossref
Crossref
Lisa Giulino-Roth & Kieron Dunleavy. 2019. Non-Hodgkin's Lymphoma in Childhood and Adolescence. Non-Hodgkin's Lymphoma in Childhood and Adolescence
185
193
.
Jeremy S. Abramson & Armando López-Guillermo. 2019. Lexikon der Medizinischen Laboratoriumsdiagnostik. Lexikon der Medizinischen Laboratoriumsdiagnostik
201
212
.
Santosha Vardhana, Paul A. Hamlin, Joanna Yang, Andrew Zelenetz, Craig S. Sauter, Matthew J. Matasar, Andy Ni, Joachim Yahalom & Craig H. Moskowitz. (2018) Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B Cell Lymphoma Treated with Second-Line Therapy and Intent to Transplant. Biology of Blood and Marrow Transplantation 24:10, pages 2133-2138.
Crossref
Crossref
Alessandro Broccoli & Pier Luigi Zinzani. (2018) The unique biology and treatment of primary mediastinal B-cell lymphoma. Best Practice & Research Clinical Haematology 31:3, pages 241-250.
Crossref
Crossref
Lisa Giulino-Roth. (2018) How I treat primary mediastinal B-cell lymphoma. Blood 132:8, pages 782-790.
Crossref
Crossref
Kieron Dunleavy & Thomas G. Gross. (2018) Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspective. Blood 132:4, pages 369-375.
Crossref
Crossref
Nirav N. Shah, Aniko Szabo, Scott F. Huntington, Narendranath Epperla, Nishitha Reddy, Siddhartha Ganguly, Julie Vose, Cynthia Obiozor, Fahad Faruqi, Alexandra E. Kovach, Luciano J. Costa, Ana C. Xavier, Ryan Okal, Abraham S. Kanate, Nilanjan Ghosh, Mohamed A. Kharfan‐Dabaja, Lauren Strelec, Mehdi Hamadani, Timothy S. Fenske, Oscar Calzada, Jonathon B. Cohen, Julio Chavez & Jakub Svoboda. (2017)
R‐
CHOP
versus
dose‐adjusted R‐
EPOCH
in frontline management of primary mediastinal B‐cell lymphoma: a multi‐centre analysis
. British Journal of Haematology 180:4, pages 534-544.
Crossref
Crossref
Mariko Yabe & L. Jeffrey Medeiros. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood
773
826
.
Kieron Dunleavy. (2017) Primary mediastinal B-cell lymphoma: biology and evolving therapeutic strategies. Hematology 2017:1, pages 298-303.
Crossref
Crossref
K. Lisenko, G. Dingeldein, M. Cremer, M. Kriegsmann, A. D. Ho, M. Rieger & M. Witzens-Harig. (2017) Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma. BMC Cancer 17:1.
Crossref
Crossref
Alessandro Broccoli, Beatrice Casadei, Vittorio Stefoni, Cinzia Pellegrini, Federica Quirini, Lorenzo Tonialini, Alice Morigi, Miriam Marangon, Lisa Argnani & Pier Luigi Zinzani. (2017) The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients. BMC Cancer 17:1.
Crossref
Crossref
Lisa Giulino-Roth, Tara O'Donohue, Zhengming Chen, Nancy L. Bartlett, Ann LaCasce, William Martin-Doyle, Matthew J. Barth, Kimberly Davies, Kristie A. Blum, Beth Christian, Carla Casulo, Sonali M. Smith, James Godfrey, Amanda Termuhlen, Matthew J. Oberley, Sarah Alexander, Sheila Weitzman, Burton Appel, Benjamin Mizukawa, Jakub Svoboda, Zeinab Afify, Melinda Pauly, Hema Dave, Rebecca Gardner, Deborah M. Stephens, William A. Zeitler, Christopher Forlenza, Jennifer Levine, Michael E. Williams, Jody L. Sima, Catherine M. Bollard & John P. Leonard. (2017) Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R. British Journal of Haematology 179:5, pages 739-747.
Crossref
Crossref
Vitaliana De Sanctis, Marco Alfò, Alice Di Rocco, Michela Ansuinelli, Eleonora Russo, Mattia F. Osti, Maurizio Valeriani, Giuseppe Minniti, Lavinia Grapulin, Daniela Musio, Stefano Bracci, Alessandra Spagnoli, Maria Luisa Moleti, Vincenzo Tombolini & Maurizio Martelli. (2017) Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: Results. Hematological Oncology 35:4, pages 554-560.
Crossref
Crossref
Justine M. KahnNmazuo W. OzuahKieron DunleavyTara O. HendersonKara Kelly & Ann LaCasce. (2017) Adolescent and young adult lymphoma: collaborative efforts toward optimizing care and improving outcomes. Blood Advances 1:22, pages 1945-1958.
Crossref
Crossref
Maurizio Martelli, Andrés Ferreri, Alice Di Rocco, Michela Ansuinelli & Peter W.M. Johnson. (2017) Primary mediastinal large B-cell lymphoma. Critical Reviews in Oncology/Hematology 113, pages 318-327.
Crossref
Crossref
Pier Luigi Zinzani & Alessandro Broccoli. (2016) Optimizing Outcomes in Primary Mediastinal B-cell Lymphoma. Hematology/Oncology Clinics of North America 30:6, pages 1261-1275.
Crossref
Crossref
Mary Gleeson, Eliza A. Hawkes, David Cunningham, Nick Chadwick, Nicholas Counsell, Anthony Lawrie, Andrew Jack, Paul Smith, Paul Mouncey, Christopher Pocock, Kirit M. Ardeshna, John Radford, Andrew McMillan, John Davies, Deborah Turner, Anton Kruger, Peter W.M. Johnson, Joanna Gambell & David Linch. (2016) Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial. British Journal of Haematology 175:4, pages 668-672.
Crossref
Crossref
Jacob R. Bledsoe, Robert A. Redd, Robert P. Hasserjian, Jacob D. Soumerai, Ha T. Nishino, Daniel F. Boyer, Judith A. Ferry, Lawrence R. Zukerberg, Nancy Lee Harris, Jeremy S. Abramson & Aliyah R. Sohani. (2016) The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome. American Journal of Hematology 91:10, pages E436-E441.
Crossref
Crossref
TP Vassilakopoulos, S Papageorgiou, GA Pangalis, S Chatziioannou, MK Angelopoulou, P Panayiotidis, K Konstantopoulos & P Rondogianni. (2016) Response to ‘PET after response to R-CHOP in primary mediastinal large B-cell lymphoma’. Leukemia 30:8, pages 1800-1801.
Crossref
Crossref
Andrea Riccardo Filippi, Cristina Piva, Mario Levis, Annalisa Chiappella, Daniele Caracciolo, Marilena Bellò, Gianni Bisi, Umberto Vitolo & Umberto Ricardi. (2016) Prognostic Role of Pre–Radiation Therapy 18F-Fluorodeoxyglucose Positron Emission Tomography for Primary Mediastinal B-Cell Lymphomas Treated with R-CHOP or R-CHOP-Like Chemotherapy Plus Radiation. International Journal of Radiation Oncology*Biology*Physics 95:4, pages 1239-1243.
Crossref
Crossref
T P Vassilakopoulos, G A Pangalis, S Chatziioannou, S Papageorgiou, M K Angelopoulou, Z Galani, G Kourti, V Prassopoulos, T Leonidopoulou, E Terpos, M N Dimopoulou, S Sachanas, C Kalpadakis, P Konstantinidou, D Boutsis, E Stefanoudaki, L Kyriazopoulou, M P Siakantaris, M-C Kyrtsonis, E Variami, I Kotsianidis, A Symeonidis, E Michali, E Katodritou, G Kokkini, C Tsatalas, H Papadaki, M-A Dimopoulos, V Sotiropoulos, V Pappa, T Karmiris, J Meletis, J Apostolidis, I Datseris, P Panayiotidis, K Konstantopoulos, P Roussou & P Rondogianni. (2015) PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy. Leukemia 30:1, pages 238-242.
Crossref
Crossref
Bouthaina S. Dabaja, Ranjana Advani, David C. Hodgson, Sughosh Dhakal, Christopher R. Flowers, Chul S. Ha, Bradford S. Hoppe, Nancy P. Mendenhall, Monika L. Metzger, John P. Plastaras, Kenneth B. Roberts, Ronald Shapiro, Sonali M. Smith, Stephanie A. Terezakis, Karen M. Winkfield, Anas Younes & Louis S. Constine. (2015) ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma. American Journal of Clinical Oncology 38:6, pages 610-620.
Crossref
Crossref
JINGJING WANG, XIANLING LIU, FANG MA, MING HUANG, YASHPAL SINGH KALLYCHURN & CHUNHONG HU. (2015) Role of radiotherapy in the treatment of primary mediastinal large B-cell lymphoma. Oncology Letters 10:5, pages 2925-2930.
Crossref
Crossref
Smith Giri, Vijaya Raj Bhatt, Ranjan Pathak, R. Gregory Bociek, Julie M. Vose & James O. Armitage. (2015)
Role of radiation therapy in primary mediastinal large
B
‐cell lymphoma in rituximab era: A
US
population‐based analysis
. American Journal of Hematology 90:11, pages 1052-1054.
Crossref
Crossref
Sheng-Hsiang Yang, Liang-Tsai Hsiao, Tzeon-Jye Chiou, Ching-Fen Yang, Yuan-Bin Yu, Chun-Yu Liu, Jyh-Pyng Gau, Jin-Hwang Liu, Po-Min Chen & Cheng-Hwai Tzeng. (2015) Rituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphoma. Journal of the Chinese Medical Association 78:7, pages 400-407.
Crossref
Crossref
Vijaya Raj Bhatt, Rajesh Mourya, Runa Shrestha & James O. Armitage. (2015) Primary mediastinal large B-cell lymphoma. Cancer Treatment Reviews 41:6, pages 476-485.
Crossref
Crossref
Jeremy S. Abramson. (2015) Transformative Clinical Trials in Non-Hodgkin and Hodgkin Lymphomas. Clinical Lymphoma Myeloma and Leukemia 15, pages S141-S146.
Crossref
Crossref
Kieron Dunleavy & Christian Steidl. (2015) Emerging Biological Insights and Novel Treatment Strategies in Primary Mediastinal Large B-Cell Lymphoma. Seminars in Hematology 52:2, pages 119-125.
Crossref
Crossref
Kieron Dunleavy & Wyndham H. Wilson. (2015) Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?. Blood 125:1, pages 33-39.
Crossref
Crossref
Kieron Dunleavy, Mark Roschewski & Wyndham H. Wilson. (2014) Precision Treatment of Distinct Molecular Subtypes of Diffuse Large B-cell Lymphoma: Ascribing Treatment Based on the Molecular Phenotype. Clinical Cancer Research 20:20, pages 5182-5193.
Crossref
Crossref
Anna Dabrowska-Iwanicka & Jan A. Walewski. (2014) Primary Mediastinal Large B-cell Lymphoma. Current Hematologic Malignancy Reports 9:3, pages 273-283.
Crossref
Crossref